Raghu R. Chivukula, MD, Ph.D., a physician-investigator in the Departments of Medicine & Surgery and the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School, is the senior author of a ...
21 minutes ago
0
0
A new study led by Indiana University School of Medicine researchers revealed a potential strategy to address neurobehavioral challenges associated with neurofibromatosis type 1, or NF1, a genetic disease that primarily affects ...
3 hours ago
0
0
Understanding how our brain interprets social hierarchy or facial emotions may be key to advancing our knowledge of anxiety and mood disorders. This is the aim of the project led by researcher Maya Visser at the Universitat ...
3 hours ago
0
0
A new clinical trial demonstrates that dietary changes significantly reduce persistent post-traumatic headaches (pPTH), a common and debilitating consequence of traumatic brain injury (TBI). Researchers from the UNC School ...
3 hours ago
0
0
According to Dr. Karolina Armonaitė, a neuroscientist from Kaunas University of Technology in Lithuania, a more precise understanding of what happens in different areas of the cerebral cortex during sleep can help diagnose ...
5 hours ago
0
0
New research from the University of Sydney reveals surgically implanted spinal cord stimulators—a common treatment for lower back pain which aims to disrupt pain signals traveling to the brain—are costly and putting patients ...
6 hours ago
0
0
A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully treated a patient with a brainstem glioma harboring a rare IDH2 mutation. The case report was published online ...
10 hours ago
0
0
Cognitive impairment is increasing globally. All stages of dementia are marked by declines in memory and executive function. Previous research has examined whether micronutrient levels may relate to cognitive resilience.
All day long, our brains carry out complicated and energy-intensive tasks such as remembering, solving problems, and making decisions.
Jul 16, 2025
0
2
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated that inhibiting GLUD1 ...
Jul 16, 2025
0
0
